(Q48123136)

8 February 2018

title

The quality of life of adults with growth hormone deficiency: comparison with diabetic patients and control subjects (English)

1 reference

8 February 2018

growth hormone deficiency

1 reference

1 reference

Wallymahmed ME

1

1 reference

8 February 2018

Foy P

series ordinal

2

1 reference

8 February 2018

MacFarlane IA

series ordinal

3

1 reference

8 February 2018

publication date

1 September 1999

1 reference

8 February 2018

published in

Clinical Endocrinology

1 reference

8 February 2018

volume

51

1 reference

8 February 2018

issue

3

1 reference

8 February 2018

page(s)

333-338

1 reference

8 February 2018

Development of a novel scale to assess life fulfillment as part of the further refinement of a quality-of-life model for epilepsy.

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00802.X

What things are important in people's lives? A survey of the public's judgements to inform scales of health related quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00802.X

Quality of life as an outcome measure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00802.X

Quality of life measures in health care. I: Applications and issues in assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00802.X

Factors influencing the desire for long-term growth hormone replacement in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00802.X

Measuring the impact of epilepsy: the development of a novel scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00802.X

Short form 36 (SF36) health survey questionnaire: normative data for adults of working age

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00802.X

Psychological well-being before and after growth hormone treatment in adults with growth hormone deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00802.X

An account of the quality of life of patients after treatment for non-functioning pituitary tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00802.X

The effect of treatment variables on mood and social adjustment in adult patients with pituitary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00802.X

Decreased psychological well-being in adult patients with growth hormone deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00802.X

Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00802.X

The development, reliability and validity of a disease specific quality of life model for adults with growth hormone deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00802.X

Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00802.X

Beneficial effects of long-term GH replacement therapy on quality of life in adults with GH deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00802.X

The hospital anxiety and depression scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00802.X

10.1046/J.1365-2265.1999.00802.X

21 January 2018

Identifiers

DOI

1 reference

8 February 2018

1 reference

8 February 2018